ABC01363AF

Telmisatran EP impurity C

Telmisatran EP Impurity C is a structurally related byproduct arising from the synthetic pathway of Telmisatran, characterized by a substituted tetrazole ring conjugated to a biphenyl moiety with a methoxy group at the para position. Its core scaffold retains the 2,4-dichlorobenzoyl functionality of the parent compound but features an additional ethyl ester linkage at the terminal carboxylic acid, distinguishing it as a partial hydrolysis intermediate. This impurity exhibits a planar conformation due to extended aromatic conjugation, enhancing its chromatographic retention profile. It serves as a critical HPLC reference standard for quantifying process-related impurities in Telmisatran drug substance analysis.

On Request
Molecular Formula C37H38N4O2
Molecular Weight 570.7000
CAS Number 144702-26-1 โœ“ Verified
PubChem CID 10076748 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Telmisatran
Lead Time On Request
IUPAC Name tert-butyl 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoate
Official Reference Standards
Std Catalog # Quantity Price
USP 1A08730 โ†— 25 mg USD 895.00

๐Ÿ“ Synonyms

Telmisartan tert-Butyl Ester 144702-26-1 Tacrolimus methylacryl aldehyde UNII-H4HLP8PW27 H4HLP8PW27 Telmisartan specified impurity C [EP] DTXSID10162789 (1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-, 1,1-dimethylethyl ester 1,1-Dimethylethyl 4'-((4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl)methyl)biphenyl-2-carboxylate TELMISARTAN IMPURITY C [EP IMPURITY]

๐Ÿ”ฌ Chemical Identifiers

CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)OC(C)(C)C)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
InChI=1S/C37H38N4O2/c1-7-12-33-39-34-24(2)21-27(35-38-30-15-10-11-16-31(30)40(35)6)22-32(34)41(33)23-25-17-19-26(20-18-25)28-13-8-9-14-29(28)36(42)43-37(3,4)5/h8-11,13-22H,7,12,23H2,1-6H3
JSCFLEBEWCTASN-UHFFFAOYSA-N

Related Products